Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Academic Health Partners (OAHP) is delighted to have been designated as an NIHR/NHSE/I Academic Health Science Centre following the recent competitive designation process. The designation comes into effect from 1 April 2020 and is for an initial period of five years.

The OAHP includes Oxford Health NHS FT, Oxford University Hospitals NHS FT, Oxford Brookes University and the University of Oxford, who have been working closely together for the last six years in key areas including clinical research, multi-disciplinary education and healthcare innovations supporting the local needs and identified priorities.

OAHP’s vision is to respond to major challenges facing healthcare such as healthy ageing, multimorbidity and mental health, antimicrobial resistance and the best use of digital tools to improve care and patient self-management.

The OAHP is currently focusing their staff, facilities and expertise to overcome the COVID-19 pandemic, and using the close collaborations between the partners to make rapid progress in areas such as clinical trials of new treatments for COVID-19 patients in the NHS.  Daily examples of the excellent work and progress in this area can be seen across the media, with partners joining colleagues across the UK and beyond.

Professor Sir John Bell, Chairman of the OAHP said: “the strength of the partners and our plans are clear in all aspects of our work and our commitment to improve every aspect of patient care, research, innovation, education and training in ways that will benefit the changing NHS and its patients as a whole.”

Professor Keith Channon, Director of the OAHP, said: “This success reflects very strong working relationships between the Partners and the intention is now to deliver even more for current challenges, ongoing patient care, and in teaching, education and training and research and innovation.”

“Each partner has its own special set of skills and areas of expertise and together the OAHP can bring these together and work not only across Oxfordshire but regionally and nationally.”

Read more on the Oxford Academic Health Partners website

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.